WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 43 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,230,026 | -55.0% | 1,323,781 | +19.5% | 0.00% | – |
| Q1 2024 | $7,175,609 | +112.8% | 1,107,347 | +26.8% | 0.00% | – |
| Q4 2023 | $3,371,471 | +187.7% | 873,438 | +59.5% | 0.00% | – |
| Q3 2023 | $1,171,973 | -17.2% | 547,651 | +18.1% | 0.00% | – |
| Q2 2023 | $1,414,937 | +17.3% | 463,914 | 0.0% | 0.00% | – |
| Q1 2023 | $1,206,176 | +31.1% | 463,914 | +3.3% | 0.00% | – |
| Q4 2022 | $920,300 | -53.1% | 448,927 | +3.1% | 0.00% | – |
| Q3 2022 | $1,963,000 | +21.2% | 435,256 | +9.9% | 0.00% | – |
| Q2 2022 | $1,620,000 | -29.5% | 396,069 | -24.1% | 0.00% | – |
| Q1 2022 | $2,297,000 | -63.4% | 522,087 | -1.0% | 0.00% | – |
| Q4 2021 | $6,284,000 | +115.1% | 527,545 | +209.8% | 0.00% | – |
| Q3 2021 | $2,921,000 | -3.3% | 170,265 | -1.7% | 0.00% | – |
| Q2 2021 | $3,020,000 | – | 173,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,437,409 | 23.87% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $10,453,380 | 5.74% |
| MPM BioImpact LLC | 2,388,011 | $5,826,747 | 0.90% |
| PFM Health Sciences, LP | 3,241,074 | $7,908,221 | 0.39% |
| Eagle Health Investments LP | 700,000 | $1,708,000 | 0.30% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,529,416 | 0.21% |
| RA Capital Management | 6,144,881 | $14,993,510 | 0.20% |
| Rubric Capital Management LP | 1,333,893 | $3,254,699 | 0.08% |
| Murchinson Ltd. | 62,500 | $152,500 | 0.02% |
| Alpine Global Management, LLC | 37,551 | $91,624 | 0.02% |